<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63122</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>アイトラッキング式認知機能評価プログラム「ミレボ」の実臨床における有用性評価</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63121</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>MSSA菌血症、セファゾリンは抗ブドウ球菌ペニシリンに非劣性／NEJM</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63120</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>コントロール不良な2型DM、orforglipron vs.ダパグリフロジン／Lancet</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63099</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>CKD合併糖尿病へのセマグルチド、心血管疾患の既往を問わず腎予後を改善（FLOW）</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63097</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>プラチナ感受性再発卵巣がんに対するmirvetuximab soravtansine＋カルボプラチンの結果（MIROVA/AGO-OVAR 2.34）／ASCO2026</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63092</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-06-29</news:publication_date>
      <news:title>日本人の心筋梗塞と大動脈解離、5年生存の違いは？</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
</urlset>
